amgen announces robust weight loss with maritide in people living with obesity or overweight at 52 weeks in a phase 2 study Nov. 26, 2024 7:05 AM ET Amgen Inc. (AMGN) ...

Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ®, and it is also part of the Nasdaq-100 Index ®, which includes the largest and most innovative non-financial ...

amgen and kyowa kirin provide top-line results from rocatinlimab phase 3 ignite study in adults with moderate to severe atopic dermatitis. mar. 08, 2025 6:00 am et kirin holdings company, ...

THOUSAND OAKS, Calif., Feb. 28, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the 45th Annual TD Cowen Health Care Conference at 9:10 a.m. ET on Wednesday, March 5, 2025. Jay Bradner ...

With over 2,000 direct employees, Amgen has the biggest operation of the pharma industry in PR. Since they started operations here in 1992, the company has invested $3.4 billion in their facilities.

With UPLIZNA receiving a label expansion that opens the door to a previously untapped rare disease market, Amgen is seeing strong returns on its USD 27.8 billion acquisition of Horizon ...

Amgen's Karol Speight discusses the trends dictating careers in the forensic analysis and wider biopharma industries.

REYKJAVIK, Iceland, Nov. 12, 2024 /PRNewswire/ -- New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing BMI alone could lower the ...

Biotech companies must develop new medicines to remain successful since older ones eventually encounter patent cliffs and face generic or biosimilar competition. However, launching new drugs is no ...

Recently, in April 2025, the FDA approved Amgen's anti-CD19 therapy, UPLIZNA, for the treatment of IgG4-related disease, ... Contact PR Newswire +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT ...